openPR Logo
Press release

A Molecular Identity Crisis - A "Ribozyme Without RNA"

11-03-2008 09:29 PM CET | Science & Education

Press release from: Austrian Science Fund FWF

/ PR Agency: PR&D - Public Relations for Research & Education
RNase P: not everything is what it seems at the molecular level.

RNase P: not everything is what it seems at the molecular level.

Not all enzymes that are assumed to require an RNA component in order to function do actually contain RNA. This surprising discovery was made during a project supported by the Austrian Science Fund FWF that focussed on the enzyme RNase P. Contrary to accepted scientific theory, the project team from Vienna has long believed that certain forms of RNase P do not contain any RNA. They have now succeeded in proving their point through a series of sophisticated experiments, the results of which are being published today in the journal CELL.


Although ribozymes are not quite living fossils, these enzymes – which function only in the presence of RNA - hail from a long gone age when biochemical processes were still controlled by RNA molecules. It was only later that proteins came onto the molecular scene. RNase P, an enzyme that modifies transfer RNAs, is one such RNA enzyme (ribozyme). All previously characterised forms of this enzyme confirmed assumptions about their RNA component. Nevertheless, evidence has also been uncovered over the past 20 years that has cast doubt on the universality of this finding and indicated that this enzyme could be made up solely of proteins. The experts certainly had plenty to debate.

Rna not always essential
But the debate seems to have been brought to an end. A group headed by Prof. Walter Rossmanith at the Medical University of Vienna has provided conclusive evidence by successfully identifying the components of human mitochondrial RNase P. Prof. Rossmanith: "RNase P is made up of three proteins that are solely responsible for the catalytic capacity of the enzyme without any RNA. This discovery has not been made before because the enzyme breaks down easily during purification due to the loose connection between its components. The approach we developed enabled us to get around this problem. That was the breakthrough that enabled us to identify the proteins." Johann Holzmann, a PhD student and member of Prof. Rossmanith's team, explains further: "The most difficult task was to track down the proteins. Everything started to move much faster once we had done that. We produced the individual proteins separately in bacteria, purified them and then used them to reconstitute mitochondrial RNase P in vitro. This finally removed any shadow of doubt for us - and CELL: mitochondrial RNase P does not contain RNA."

Reinventing the Wheel
The identification of the three proteins also resolved another previously unanswered question in molecular evolution research: How is a ribozyme replaced by a protein enzyme? The answer provided by data collected during the project is that the protein-only mitochondrial RNase P developed in parallel to a pre-existing ribozyme. Eventually, it replaced the latter. It is interesting to note that the three protein components have been recruited from entirely different biochemical pathways and yet they have nevertheless retained their original functions. Prof. Rossmanith adds: "We are also calling mitochondrial RNase P a patchwork enzyme, because it seems to be assembled from components available by chance at the time of its appearance in evolution." It is still unclear why only animal mitochondrial RNase P and not all ribozymes have been replaced by protein enzymes. Indeed, the results of this successful FWF project have opened the door to a whole range of questions - and answers.



Image and text will be available online from Monday, 3rd November 2008,
11.00 a.m. CET onwards:
http://www.fwf.ac.at/en/public_relations/press/pv200811-en.html



Original publication:
"RNase P without RNA: Identification and functional reconstitution of the
human mitochondrial tRNA processing enzyme"
J. Holzmann, P. Frank, E. Löffler, K. Bennett, C. Gerner & W. Rossmanith.
Cell 135, 462-474, October 31, 2008, DOI 10.1016/j.cell.2008.09.013

The purpose of the FWF is to support the ongoing development of Austrian science and basic research at a high international level. In this way, the FWF makes a significant contribution to cultural development, to the advancement of our knowledge-based society, and thus to the creation of value and wealth in Austria.

Scientific Contact:
Walter Rossmanith, PhD Medical
University of Vienna
Center for Anatomy & Cell Biology
Währingerstr. 13
1090 Vienna
Austria
M 0664 / 800 16 37 512
E walter.rossmanith@meduniwien.ac.at

Austrian Science Fund FWF:
Mag. Stefan Bernhardt
Haus der Forschung
Sensengasse 1
1090 Vienna
Austria
T +43 / 1 / 505 67 40 - 8111
E stefan.bernhardt@fwf.ac.at

Editing & Distribution:
PR&D - Public Relations for Research & Education
Campus Vienna Biocenter 2
1030 Vienna
Austria
T +43 / 1 / 505 70 44
E contact@prd.at
W http://www.prd.at

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release A Molecular Identity Crisis - A "Ribozyme Without RNA" here

News-ID: 58499 • Views:

More Releases from Austrian Science Fund FWF

Human rights: Extrajudicial complaint mechanisms particularily suitable
Reconciling corporate interests with human rights is a difficult endeavour. A research project funded by the Austrian Science Fund FWF demonstrates that non-judicial complaint mechanisms may be an adequate avenue for conflict resolution. For a number of years, companies have been facing increased pressure when it comes to human rights violations. Numerous multinational corporations such as Shell Oil, Texaco or Unocal were accused of such violations, resulting in years of
Body language in the classroom
Body language plays a crucial role, particularly in communication between teachers and students. This is the outcome of a project funded by the Austrian Science Fund FWF which focused on the hidden elements of teaching. An encouraging smile, a sceptical frown, a negating shake of the head: body language is very diverse and effective. With the discovery of mirror neurons, brain researchers corroborated its impact by demonstrating how these nerve cells
Art history – In the eye of the beholder
What viewers of a work of art see and feel is informed by their socio-cultural background and by how familiar they are with the image. Art historians have now verified this theory with the help of methods that are usually used in psychology. This project is funded by the Austrian Science Fund FWF. The influence culture has on an individual's experience and behaviour is a long-standing object of research
Targeting chronic pain
With the support of the Austrian Science Fund FWF, the neurophysiologist Ruth Drdla-Schutting is investigating the role astrocytes play in the genesis of chronic pain. With the help of innovative gene technology (DREADDs), scientists are tailoring treatment specifically to these cells that are the most numerous found in the central nervous system. Pain is an important protection system of the human body. But when it becomes chronic, as it frequently

All 4 Releases


More Releases for RNase

RNase Control Market Dynamics Evolve with Biopharma Advances - Persistence Marke …
✅ Market Overview and Growth Outlook The RNase control market plays a critical role in modern molecular biology by safeguarding the integrity of RNA during various experimental procedures. RNase, or ribonuclease, is an enzyme that breaks down RNA into smaller fragments. Given RNA's sensitivity to degradation, the presence of RNase during processes such as cDNA synthesis, RNA purification, and real-time polymerase chain reactions (RT-PCR) can severely compromise experimental outcomes. As
Recombinant RNase Inhibitor Market Size, Share and Forecast By Key Players-Therm …
𝐔𝐒𝐀, 𝐍𝐞𝐰 𝐉𝐞𝐫𝐬𝐞𝐲- According to the MRI Team's Market Research Intellect, the global Recombinant RNase Inhibitor market is anticipated to grow at a compound annual growth rate (CAGR) of 10.8% between 2024 and 2031. The market is expected to grow to USD 47.65 Billion by 2024. The valuation is expected to reach USD 97.69 Billion by 2031. The market for recombinant RNase inhibitors is expanding significantly as a result of the growing interest in RNA-based
RNase and DNase Free Pipette Tips Market - Unlocking Peace of Mind: Elevate Your …
Newark, New Castle, USA - new report, titled RNase and DNase Free Pipette Tips Market The report has been put together using primary and secondary research methodologies, which offer an accurate and precise understanding of the RNase and DNase Free Pipette Tips market. Analysts have used a top-down and bottom-up approach to evaluate the segments and provide a fair assessment of their impact on the global RNase and DNase Free
RNase and DNase Free Pipette Tips Market SWOT Analysis, Size Comprehensive Analy …
The report extensively examines the global RNase and DNase Free Pipette Tips market while focusing on the leading companies and their business strategies, geographical growth, market segmentation, competitive environment, production, price, and cost structures. Each section of the research report has been carefully designed to examine important facets of the global market for RNase and DNase Free Pipette Tips . For instance, the market dynamics section delves deeply into the
RNase and DNase Free Pipette Tips Market to hit new heights worth US$ 2.8 billio …
Newark, New Castle, USA - RNase and DNase Free Pipette Tips market research report is a complete study of market dynamics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends, and strategies. It analyses the market's historical and projected growth by region and compares it to other markets. The report includes detailed market information such as regional market opportunities, sales and revenue by region, cost analysis,
RNase Control Market Trends, Demand Growth Revenue Analysis Report to 2032 | Asu …
The Global RNase Control Market 2022-2032 report is a collection of details related to industry performance. Every aspect is studied in detail in the research report. The market analysis report provides comprehensive analysis of all the financial topics associated with the RNase Control industry. The growth pattern seen in the RNase Control industry performance over the time is studied in the market report. The study helps in providing thorough understanding